Redemption Of Bonds FinCF、減価償却費、投資有価証券売却損益（△は益）他2件
- 【期間】
| 年度 | Redemption Of Bonds FinCF | 減価償却費 | 投資有価証券売却損益（△は益） | Accounts Payable Trade | 売上高 - 医薬品 |
|---|
| 2009/12 | - | | 24.1億 | | 85百万 | | - | | - | |
| 2010/12 | - | | 20.7億 | -14.1% | -340百万 | 赤転 | - | | - | |
| 2011/12 | - | | 19.3億 | -7.2% | - | | - | | - | |
| 2014/12 | - | | - | | - | | - | | 455億 | |
| 2015/12 | - | | - | | - | | - | | 479億 | +5.2% |
| 2016/12 | - | | - | | - | | - | | 473億 | -1.3% |
| 2017/12 | - | | - | | - | | - | | 498億 | +5.3% |
| 2018/12 | - | | - | | - | | - | | 477億 | -4.3% |
| 2019/12 | - | | - | | - | | - | | 403億 | -15.5% |
| 2020/12 | - | | - | | - | | - | | 445億 | +10.4% |
| 2021/12 | - | | - | | - | | - | | 419億 | -5.7% |
| 2022/12 | - | | - | | - | | - | | 436億 | +4.1% |
| 2023/12 | - | | - | | - | | - | | 486億 | +11.4% |
